Search research articles
Contact Us
Filters
Showing results (261-270 of 441) with videos related to
Page
of 45
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 16, 2021
Effectiveness of direct-acting antivirals for chronic hepatitis C treatment in migrant and non-migrant populations in France
Tchadine Djaogol, Hélène Fontaine, Maël Baudoin, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
February 6, 2022
Elevated coffee consumption is associated with a lower risk of elevated liver fibrosis biomarkers in patients treated for chronic hepatitis B (ANRS CO22 Hepather cohort)
Tangui Barré, Hélène Fontaine, Clémence Ramier, et al.
Journal of Hepatology
|
March 20, 2004
Intrahepatic hepatitis C virus RNA quantification in microdissected hepatocytes
Giovanna Vona, Rosella Tuveri, Oona Delpuech, et al.
Gut
|
October 10, 2015
Hepatitis C virus treatment in the real world: optimising treatment and access to therapies
Fabien Zoulim, T Jake Liang, Alexander L Gerbes, et al.
Hepatology (Baltimore, Md.)
|
March 18, 2009
SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C
Giada Sebastiani, Philippe Halfon, Laurent Castera, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 17, 2005
Spontaneous hepatic decompensation in patients coinfected with HIV and hepatitis C virus during interferon-ribavirin combination treatment
Firouzé Bani-Sadr, Fabrice Carrat, Eric Rosenthal, et al.
Journal of Hepatology
|
June 3, 2014
Role of a 48-week pegylated interferon therapy in hepatitis B e antigen positive HIV-co-infected patients on cART including tenofovir: EMVIPEG study
Patrick Miailhes, Marianne Maynard-Muet, Fanny Lebossé, et al.
Plos One
|
January 5, 2012
Gaining greater insight into HCV emergence in HIV-infected men who have sex with men: the HEPAIG Study
Christine Larsen, Marie-Laure Chaix, Yann Le Strat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2006
Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs
Caroline Besson, Danielle Canioni, Eric Lepage, et al.
Journal of Hepatology
|
March 22, 2014
Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141)
Sylvie Deuffic-Burban, Michaël Schwarzinger, Dorothée Obach, et al.
Page
of 45
Search research articles
Search
Showing results (261-270 of 441) with videos related to
Sort By:
Page
of 45
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 16, 2021
Effectiveness of direct-acting antivirals for chronic hepatitis C treatment in migrant and non-migrant populations in France
Tchadine Djaogol, Hélène Fontaine, Maël Baudoin, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
February 6, 2022
Elevated coffee consumption is associated with a lower risk of elevated liver fibrosis biomarkers in patients treated for chronic hepatitis B (ANRS CO22 Hepather cohort)
Tangui Barré, Hélène Fontaine, Clémence Ramier, et al.
Journal of Hepatology
|
March 20, 2004
Intrahepatic hepatitis C virus RNA quantification in microdissected hepatocytes
Giovanna Vona, Rosella Tuveri, Oona Delpuech, et al.
Gut
|
October 10, 2015
Hepatitis C virus treatment in the real world: optimising treatment and access to therapies
Fabien Zoulim, T Jake Liang, Alexander L Gerbes, et al.
Hepatology (Baltimore, Md.)
|
March 18, 2009
SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C
Giada Sebastiani, Philippe Halfon, Laurent Castera, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 17, 2005
Spontaneous hepatic decompensation in patients coinfected with HIV and hepatitis C virus during interferon-ribavirin combination treatment
Firouzé Bani-Sadr, Fabrice Carrat, Eric Rosenthal, et al.
Journal of Hepatology
|
June 3, 2014
Role of a 48-week pegylated interferon therapy in hepatitis B e antigen positive HIV-co-infected patients on cART including tenofovir: EMVIPEG study
Patrick Miailhes, Marianne Maynard-Muet, Fanny Lebossé, et al.
Plos One
|
January 5, 2012
Gaining greater insight into HCV emergence in HIV-infected men who have sex with men: the HEPAIG Study
Christine Larsen, Marie-Laure Chaix, Yann Le Strat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2006
Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs
Caroline Besson, Danielle Canioni, Eric Lepage, et al.
Journal of Hepatology
|
March 22, 2014
Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141)
Sylvie Deuffic-Burban, Michaël Schwarzinger, Dorothée Obach, et al.
Page
of 45